Clario Selects TransPerfect Technology to Reduce Translation Turnaround Time by 30%

GlobalLink Applanga solution shortens eCOA study initiation time and increases global patient participation in clinical trials

New York and Philadelphia, October 31 March 2022 /PRNewswire/ — TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that Clario has selected its GlobalLink Applanga technology to simplify the translation process.

Clario is a healthcare technology company providing leading endpoint technology solutions for decentralized (DCT), hybrid and site-based clinical trials. Clario’s Translation Workbench is used to simplify the localization process, including managing multilingual content for licensing scales and data collection materials, as well as ensuring on-screen accuracy. Managing approximately 150 studies at a time, each using an average of 20 languages ​​and 8 assessments, Clario needed technology that could provide them with automation to speed up the eCOA study launch process.

GlobalLink Applanga is a cloud-based translation management system with features developed for web-based applications, including handheld devices and clinical applications, enabling Clario to meet application localization requirements more efficiently.

Connected to Applanga via an API, Clario Translation Workbench initiates the localization process and simplifies screenshot review and approval. Screenshots are automatically captured for each assessment, making it easy to extract text and push screenshots.

Clario’s turnaround time decreased by 30% due to the implementation of Applanga. These reductions are achieved by reducing communication time between TransPerfect and Clario, eliminating the manual work required to generate accurate screenshots and translations on the eCOA application, and minimizing defects and human error, thereby alleviating quality assurance burden of personnel.

“Our clients need to deploy studies in multiple countries and ensure that patients have access to accurate and timely translations of electronic clinical outcome assessments. Without these, pharmaceutical and biopharmaceutical clients would face delays in delivering new medicines to patients, who may not be able to obtain information about them Important information for health. With Clario’s global reach and TransPerfect’s technology, we can help increase patient access and speed up overall study setup time,” said Terry BurkeExecutive Vice President eCOA.

TransPerfect President and CEO Phil Shaw Commenting, “Clario has integrated Applanga in a way that enables them to improve quality and efficiency. We are delighted that our technology has helped them reduce risk, reduce costs, and successfully bring the treatment to market safely and quickly. duty of.”

About Clarion

Clario is a leading technology company providing our pharmaceutical, biotech and medical device partners with the industry’s richest clinical evidence. In decentralized and site-based trials, our deep scientific expertise, global scale and the industry’s broadest endpoint technology platform enable our partners to transform lives.Clarion’s trial is everywhere For more than 20 years, solutions have powered mixed and decentralized clinical trials (DCTs), enabling sponsors to collect high-quality endpoint data from any modality or location, while improving patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. Clario’s global team of scientific, technical and operational experts has 30 facilities in 9 countries and has helped deliver more than 19,000 trials and 870 regulatory approvals. 5 meters Patients in 120 countries. For 50 years, our innovations have been transforming clinical trials.

About TransPerfect

TransPerfect is the world’s largest provider of global business language and technology solutions. With offices in more than 100 cities on six continents, TransPerfect provides a full range of services to clients around the world in more than 200 languages. Over 6,000 Global Organizations Use TransPerfect’s GlobalLink® Technology that simplifies multilingual content management. With an unparalleled commitment to quality and customer service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect’s global headquarters are located in New YorkRegional headquarters are located in London and Hongkong. For more information, please visit our website


Source link